NCT03231956View on ClinicalTrials.gov

CLEAR Sepsis Clinical Study

UnknownOBSERVATIONAL
Enrollment

182

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

June 30, 2022

Conditions
Sepsis
Interventions
DEVICE

ClearSight™ / EV1000NI Clinical Platform

Noninvasive Hemodynamic Monitoring utilizing ClearSight TM System

Trial Locations (5)

48085

TERMINATED

Beaumont Hospital, Troy, Troy

48201

RECRUITING

Detroit Receiving Hospital, Detroit

48235

RECRUITING

Sinai-Grace Hospital, Detroit

48236

RECRUITING

Ascension St. John Hospital, Detroit

48703

TERMINATED

Beaumont Hospital, Royal Oak, Royal Oak

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY